Acute radiation-induced lung injury in the rhesus macaque and its' treatment byipw-5371, a small molecule inhibitor of TGF# receptor-1 kinase

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201800012C
Awardee
Awarding agency
Obligated
$5,597,977

Award facts

Opportunity
  • HHSNIHNIAIDBAA20171 Solicitation number
Contract value 100% obligated
$5,597,977.39 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 12 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Palo Alto, CA 94301, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00020 · To DE-obligate remaining funds and administratively close the contract. -$1,204
Funding Only Action P00019 · Deobligate funds from line items -$66
Other Administrative Action P00018 $0
Other Administrative Action P00017 · IPP-B: acute radiation-induced lung injury in the rhesus macaque and its' treatment byipw-5371, a small molecule inhibitor of TGF# receptor-1 kinase. $0
Other Administrative Action P00016 $0
Other Administrative Action P00015 $0
Other Administrative Action P00014 $113,773
Other Administrative Action P00013 $0
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Exercise an Option P00008 $1,996,366
Other Administrative Action P00007 · To modify article B.3., advanced understandings and articles I.2., authorized substitution of clauses and article I.3., additional contract clauses. $0
Change Order P00006 · To revise article B.3., and article F.1., and article G.1. And provide funds in the amount of $235,140. $235,140
Other Administrative Action P00005 · To revise article B.3., advance understandings, subcontracts to reflect the changes $0
Exercise an Option P00004 · To exercise option 1, year 2, period 04/01/19 - 03/31/20. $2,080,493
Other Administrative Action P00003 · To revise 1) article B.2, B.3., F.1., and section J and K to reflect the change. $0
Other Administrative Action P00002 · To replace subcontractor snbl USA LTD. In its entirety with altasciences preclinical seattle LLC. $0
Other Administrative Action P00001 $0
Original award $1,173,475
Show all 21

About this award

Written by GovTribe AI ·

Innovation Pathways, LLC was awarded a $5,597,977.39 cost-no-fee definitive contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to conduct research on "Acute Radiation-Induced Lung Injury in the Rhesus Macaque and Its' Treatment by IPW-5371, A Small Molecule Inhibitor of TGF# Receptor-1 Kinase." Under this contract, Innovation Pathways will deliver research services to study the effects of IPW-5371, an inhibitor of transforming growth factor beta receptor-1 kinase, on acute radiation-induced lung injury in rhesus macaques. The period of performance is from April 1, 2018 through September 30, 2023. No set-aside designation was used for this award made by the NIH to address acute radiation-induced lung injury.

Quick answers

Who was awarded contract HHSN272201800012C?

HHSN272201800012C was awarded to Innovation Pathways, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2018.

How much is contract HHSN272201800012C worth?

The government has obligated $5,597,977 on HHSN272201800012C.

Was contract HHSN272201800012C competed?

The extent of competition for HHSN272201800012C was full and open competition. The government received 12 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login